Figure 2.
Changes in HBV DNA level after CHC treatment. Two of the 13 patients whose baseline HBV DNA was <2,000 IU/mL developed viral replication after HCV treatment (marked as*), while the HBV DNA levels of the other patients remained stable. Two of the three patients with baseline HBV DNA levels >2,000 IU/mL had no detectable HBV DNA at the end of treatment.